SYSTM Wealth Solutions LLC Has $1.13 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

SYSTM Wealth Solutions LLC increased its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 86.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,844 shares of the biotechnology company's stock after buying an additional 1,778 shares during the period. SYSTM Wealth Solutions LLC's holdings in Axon Enterprise were worth $1,131,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. ICA Group Wealth Management LLC bought a new stake in shares of Axon Enterprise during the 4th quarter worth about $26,000. Blue Trust Inc. boosted its holdings in Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company's stock valued at $27,000 after acquiring an additional 79 shares during the period. Trivant Custom Portfolio Group LLC acquired a new stake in Axon Enterprise in the 1st quarter valued at approximately $31,000. First PREMIER Bank acquired a new stake in shares of Axon Enterprise in the first quarter worth $33,000. Finally, Rise Advisors LLC increased its position in Axon Enterprise by 49.0% during the first quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company's stock worth $45,000 after acquiring an additional 47 shares during the period. Institutional investors own 79.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on AXON shares. Jefferies Financial Group began coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They set a "buy" rating and a $385.00 price objective for the company. Barclays upped their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a report on Wednesday, August 7th. Robert W. Baird lifted their price objective on Axon Enterprise from $360.00 to $400.00 and gave the stock an "outperform" rating in a report on Tuesday, September 10th. Northland Securities upped their target price on Axon Enterprise from $330.00 to $365.00 and gave the company an "outperform" rating in a research note on Thursday, August 8th. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $400.00 target price on shares of Axon Enterprise in a research report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus target price of $365.38.

Insiders Place Their Bets

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total value of $167,863.50. Following the completion of the transaction, the director now owns 7,379 shares in the company, valued at approximately $2,752,588.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $380.99, for a total transaction of $380,990.00. Following the completion of the sale, the director now owns 27,259 shares in the company, valued at approximately $10,385,406.41. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total transaction of $167,863.50. Following the completion of the transaction, the director now owns 7,379 shares in the company, valued at $2,752,588.37. The disclosure for this sale can be found here. Insiders have sold a total of 317,981 shares of company stock valued at $115,662,734 in the last 90 days. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Price Performance

Axon Enterprise stock traded up $0.44 during trading hours on Wednesday, hitting $383.01. 401,981 shares of the stock were exchanged, compared to its average volume of 519,180. The stock has a market capitalization of $28.90 billion, a P/E ratio of 111.85, a P/E/G ratio of 10.30 and a beta of 0.94. The business's 50-day moving average is $342.26 and its two-hundred day moving average is $315.72. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. Axon Enterprise, Inc. has a 12 month low of $189.12 and a 12 month high of $387.31.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping analysts' consensus estimates of $1.02 by $0.18. The business had revenue of $504.00 million for the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. Axon Enterprise's revenue for the quarter was up 34.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.80 EPS. Equities research analysts expect that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.